Protocolo diagnóstico de la uretritis en el adulto sexualmente activo

  1. Arizcorreta Yarza, A. 1
  2. Quiles Machado, J.A. 1
  3. Palomar Muñoz, M.C. 1
  4. Gerez Neira, D.V.
  1. 1 Servicio de Medicina Interna General, Enfermedades Infecciosas y Cuidados Paliativos. Hospital Universitario Puerta del Mar, Cádiz
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Any de publicació: 2022

Títol de l'exemplar: Enfermedades infecciosas (VI)

Sèrie: 13

Número: 54

Pàgines: 3186-3191

Tipus: Article

DIALNET GOOGLE SCHOLAR

Altres publicacions en: Medicine: Programa de Formación Médica Continuada Acreditado

Resum

Urethritis is a syndrome characterized by urethral inflammation which may lead to urethral secretion and/or dysuria. Cervicitis is the female equivalent and is characterized by inflammation of and secretion from endocervical mucosa. In sexually active adults, sexually transmitted infections (STI) are the most common etiology, with greater prevalence among certain risk groups. Although Neisseria gonorrhoeae and Chlamydia trachomatis are the most common etiological agents, other microorganisms of growing interest (Micoplasma genitalium, Trichomonas vaginalis) may be involved. The presumed diagnosis is based on symptoms of urethritis together with the presence of leukocytes in urethral/cervical secretions or in urine. Diagnostic confirmation is made via real-time polymerase chain reaction (PCR) tests and/or a urethral exudate culture. The aim of treatment is to identify and treat infected people before they develop complications and to decrease or avoid transmission and reinfection.

Referències bibliogràfiques

  • Horner P, Blee K, Falk L, Van der Mejiden W. European Guideline on the management of non gonococcal urethritis. Int J STD AIDS. 2016;27:928-37.
  • Pond MJ, Nori AV, Witney AA, Lopeman RC, Butcher PD, Sadiq ST. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for rutine testing and the inadequacy of current treatment options. Clin Infect Dis. 2014; 58:631-7
  • Unemo M. Current and future antimicrobial treatment of gonorrhoea. The rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis. 2015;364:1029-32
  • St Cyr S, Barbee L, Workowski KA, Bachmann LH, Pham C, Schlanger K. Update to CDC ́s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Wkly Rep. 2020;69:1911-6.
  • Geisler W, Uniyal A, Lee J, Lensing S, Johnson S, Perry R. Azithromycin versus doxycycline for urogenital Chlamydia trachomatis infection. New Engl J Med. 2015;373:2512-21.
  • Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FY. The efficacy of azithromycin for the treatmeant of genital Micoplasma genitalium: a systematic review and meta-analysis. Clin Infec Dis. 2015;61:1389-99
Fuente de los datos: Dialnet